US 8802090
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 8802090 (Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers) held by PRECISION BIOLOGICS, INC. expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION BIOLOGICS, INC.
- Grant date
- Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K45/06, A61K47/6859